Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Nora Chokr"'
Publikováno v:
SSM: Qualitative Research in Health, Vol 3, Iss , Pp 100215- (2023)
As the prevalence of pediatric diabetes grows and new technologies to manage diabetes emerge, there is increasing concern about consistency in health management across institutional settings, particularly in schools. While much is known about barrier
Externí odkaz:
https://doaj.org/article/a64acd6bc1ff43ca92c5958fdc6dafa8
Publikováno v:
Advances in Hematology, Vol 2018 (2018)
Myelodysplastic syndromes (MDS) are a heterogeneous group of diseases characterized by ineffective hematopoiesis and a wide spectrum of manifestations ranging from indolent and asymptomatic cytopenias to acute myeloid leukemia (AML). MDS result from
Externí odkaz:
https://doaj.org/article/bd3b53acfef940e8b0d428a6cf056560
Publikováno v:
Case Reports in Oncological Medicine, Vol 2018 (2018)
Background. Anti-PD-1 agents were approved for advanced melanoma after the landmark trial Checkmate-037. Anti-PD-1 agents can breach immunologic tolerance. Fulminant diabetes is an immune endocrinopathy that results from a violent immune attack leadi
Externí odkaz:
https://doaj.org/article/7c0f1f9ca030493693c25a574c99cbf7
Autor:
Nora Chokr, Alexandra Gomez-Arteaga
Publikováno v:
Seminars in Hematology. 60:34-41
Outcomes of Cord Blood Vs Adult Stem Cell Sources in Patients with Mutated TP53 Myeloid Malignancies
Autor:
Nora Chokr, Dr. Joshua A Fein, Tsiporah B. Shore, Sebastian Mayer, Jingmei Hsu, Danielle Guarneri, Pinkal Desai, Adrienne A Phillips, Michael B. Samuel, Ellen K. Ritchie, Gail J. Roboz, Koen van Besien, Alexandra Gomez-Arteaga
Publikováno v:
Transplantation and Cellular Therapy. 29:S120-S121
Autor:
Mohammad Alhomoud, Nora Chokr, Alexandra Gomez-Arteaga, Zhengming Chen, Joanna G. Escalon, Alan C. Legasto, Geraldine Brusca-Augello, Samuel Yamshon, Markus Plate, Dana Zappetti, Jing-Mei Hsu, Adrienne Phillips, Sebastian Mayer, Tsiporah Shore, Koen Van Besien
Publikováno v:
Transplantation and Cellular Therapy. 29:326.e1-326.e10
Publikováno v:
Expert Review of Hematology. 11:715-726
Myelodysplastic syndromes (MDS) encompass a heterogenous collection of clonal hematopoietic stem cell disorders defined by dysregulated hematopoiesis, peripheral cytopenias, and a risk of leukemic progression. Increasing data support the role of inna
Publikováno v:
Case Reports in Oncological Medicine, Vol 2018 (2018)
Case Reports in Oncological Medicine
Case Reports in Oncological Medicine
Background. Anti-PD-1 agents were approved for advanced melanoma after the landmark trial Checkmate-037. Anti-PD-1 agents can breach immunologic tolerance. Fulminant diabetes is an immune endocrinopathy that results from a violent immune attack leadi
Autor:
Nora Chokr, Howard Look, Jenise C. Wong, Brandon Arbiter, Saleh Adi, Aaron B. Neinstein, Cassie Ross
Publikováno v:
Journal of diabetes science and technology, vol 11, iss 4
Background: A novel software application, Blip, was created to combine and display diabetes data from multiple devices in a uniform, user-friendly manner. The objective of this study was to test the usability of this application by adults and caregiv
Autor:
Jan Philipp Bewersdorf, Nora Chokr, Amer M. Zeidan, Maximilian Stahl, Alexander B Pine, Rory M. Shallis
INTRODUCTION: Commonly used scoring systems rely on blood counts, histological and cytological examination of bone marrow and peripheral blood, and cytogenetic assessments to estimate prognosis of patients with myelodysplastic syndromes (MDS) and gui
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f099a431d5e1a5e921c9fef8d5eeb269
https://europepmc.org/articles/PMC6540985/
https://europepmc.org/articles/PMC6540985/